Pharma's Almanac

5692 Articles Available

1 238

Consulting

Supporting Drug Development – Increasing Probability of Success

PAO-03-23-CL-04

Strategic Partnership

Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications

PR-M03-23-06

Tumor Microenvironment

Harnessing the Power of the Tumor Microenvironment with First-in-Class Therapies

PAO-03-23-CL-01

Bone Regeneration

A Novel Technology Platform for Bone Regeneration and Cancer Treatment

PAO-03-23-CL-06

New Biomanufacturing Facility

Samsung Biologics Announces Construction of Plant 5 to Commence Bio Campus II Capacity Expansion

PR-M03-23-05

CDMO Leadership Award

Olon Has Been Selected as Champion in Five Categories of 2023 CDMO Leadership Awards

PR-M03-23-04

Point of Care

Helping Clinicians Make Better Decisions More Easily

PAO-03-23-CL-05

Biomanufacturing

On the Journey to a New Industry Standard for E. coli-based Protein Production

PAO-03-23-CL-03

Cloud-Based Platform

Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data

PR-M03-23-03

Viral Vector Manufacturing

Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control

PAO-02-23-CL-03

New R&D Center

Addition of New U.S. R&D Center is the Next Step in Asymchem’s Globalization Strategy

PAO-02-23-CL-07

mRNA Ultra-Cold Chain Management

Ultra-Cold Chain and Supply Chain Management Strategies for mRNA

PAO-02-23-CL-09

UN Global Compact

CDMO Joins United Nations Global Compact

PR-M03-23-02

CDMO Leadership Award

Hovione Receives the 2023 CDMO Leadership Award in All Six Categories and Is Champion in Compatibility and Expertise

PR-M03-23-01

Data-Driven Patient Matching

Accelerating Oncology Clinical Trials with Deep Digitalization of Patient Data

PAO-03-23-CL-02

Digital Twin Technology

The Powerful Potential of Digital Twin Technology to Improve Drug Discovery, Development, Manufacturing, and More

PAO-03-23-NI-02

FDA New Drug Approvals

Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down

PAO-03-23-NI-03

Interchangeable Biosimilars

The Opportunities and Challenges Posed by Biosimilar Interchangeability

PAO-03-23-NI-01

Scale-Up

Scale-Up Expertise to Support Your Biologics Life Cycle

PAO-02-23-CL-06

Kidney Disease

Ascelia Pharma Meets Major Milestone with Patient Enrollment Completion of Phase 3 Study for Orviglance, Novel MRI Contrast Agent for Patients with Kidney Impairment

PR-M02-23-04

T Cell Expansion Platform

Terumo Blood and Cell Technologies Presents First Quantum® Flex Data for Multiple Size Bioreactors Showing Rapid T Cell Expansion to Numbers Equivalent of a Therapeutic Dose

PR-M02-23-03

New CDMO Facility

Leveraging a State-of-the-Art CDMO Facility to Advance Healthcare

PAO-02-23-PATV-04

Academic Research

Olon and The Chemistry Department of Politecnico University Launch a Research Project on Polymorphism and Characterization of API Solid State

PR-M02-23-02

Biopharma Facility Design

Growing a Global Presence with a Continued Focus on Life Sciences Facilities

PAO-02-23-PATV-03

1 238

Content Filter

5692 Articles Available

Can't find what you're looking for? Try our advanced search.

Consulting

Supporting Drug Development – Increasing Probability of Success

Strategic Partnership

Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications

Tumor Microenvironment

Harnessing the Power of the Tumor Microenvironment with First-in-Class Therapies

Bone Regeneration

A Novel Technology Platform for Bone Regeneration and Cancer Treatment

New Biomanufacturing Facility

Samsung Biologics Announces Construction of Plant 5 to Commence Bio Campus II Capacity Expansion

CDMO Leadership Award

Olon Has Been Selected as Champion in Five Categories of 2023 CDMO Leadership Awards

Point of Care

Helping Clinicians Make Better Decisions More Easily

Biomanufacturing

On the Journey to a New Industry Standard for E. coli-based Protein Production

Cloud-Based Platform

Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data

Viral Vector Manufacturing

Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control

New R&D Center

Addition of New U.S. R&D Center is the Next Step in Asymchem’s Globalization Strategy

mRNA Ultra-Cold Chain Management

Ultra-Cold Chain and Supply Chain Management Strategies for mRNA

UN Global Compact

CDMO Joins United Nations Global Compact

CDMO Leadership Award

Hovione Receives the 2023 CDMO Leadership Award in All Six Categories and Is Champion in Compatibility and Expertise

Data-Driven Patient Matching

Accelerating Oncology Clinical Trials with Deep Digitalization of Patient Data

Digital Twin Technology

The Powerful Potential of Digital Twin Technology to Improve Drug Discovery, Development, Manufacturing, and More

FDA New Drug Approvals

Many First-in-Class Drugs Approved by FDA in 2022, but Overall Approval Numbers Down

Interchangeable Biosimilars

The Opportunities and Challenges Posed by Biosimilar Interchangeability

Scale-Up

Scale-Up Expertise to Support Your Biologics Life Cycle

Kidney Disease

Ascelia Pharma Meets Major Milestone with Patient Enrollment Completion of Phase 3 Study for Orviglance, Novel MRI Contrast Agent for Patients with Kidney Impairment

T Cell Expansion Platform

Terumo Blood and Cell Technologies Presents First Quantum® Flex Data for Multiple Size Bioreactors Showing Rapid T Cell Expansion to Numbers Equivalent of a Therapeutic Dose

New CDMO Facility

Leveraging a State-of-the-Art CDMO Facility to Advance Healthcare

Academic Research

Olon and The Chemistry Department of Politecnico University Launch a Research Project on Polymorphism and Characterization of API Solid State

Biopharma Facility Design

Growing a Global Presence with a Continued Focus on Life Sciences Facilities